Yale University

Evaluating interventions to improve antiretroviral adherence: how much of an effect is required for favorable value?

TitleEvaluating interventions to improve antiretroviral adherence: how much of an effect is required for favorable value?
Publication TypeJournal Article
Year of Publication2010
AuthorsBraithwaite, Scott R., David A. Fiellin, Kimberly Nucifora, Kendall Bryant, Mark Roberts, Nancy Kim, and Amy C. Justice
JournalValue in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Volume13
Issue5
Pagination535-42
Date Published2010 Aug
ISSN1524-4733
KeywordsAcquired Immunodeficiency Syndrome, Anti-HIV Agents, Computer Simulation, Cost-Benefit Analysis, Disease Progression, Health Services, Humans, Kaplan-Meier Estimate, Life Expectancy, Medication Adherence, Patient Acceptance of Health Care, Risk, Risk Factors, Treatment Outcome, United States
AbstractUncertainty about the value of antiretroviral therapy (ARV) adherence interventions may be a barrier to implementation and evaluation. Our objective is to estimate the minimum effectiveness required for ARV adherence interventions to deliver acceptable value.
DOI10.1353/hpu.2012.0006
Alternate JournalValue Health

External Links